Pharmalot Matthew Herper STAT Plus: Pharmalittle: We’re watching a Cytokinetics deal with Royalty Pharma, Cue Health shutting down, and more
Pharmalot Jonathan Wosen STAT Plus: Pharmalittle: We’re watching a ban of compounded versions of GLP-1s, a Biogen acquisition, and more
Pharmalot Allison DeAngelis STAT Plus: Pharmalittle: We’re watching BIO layoffs, AstraZeneca plans to double revenue, and more
Pharmalot Andrew Joseph STAT Plus: Pharmalittle: We’re reading about Sanders’ pharma pressure campaign, AstraZeneca’s new ADC factory, and more
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about an Amgen drug for lung cancer, a Novo plant fire, and more
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about a Roche obesity drug, an experimental Lilly insulin, and more
Pharmalot Ed Silverman STAT Plus: Getting abortion pills through the mail is safe, quick, and effective, study finds
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about fake studies, AbbVie investing in psychiatric meds, and more
Pharmalot Ed Silverman STAT Plus: Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about Pfizer’s DTC platform, Sandoz’s feud with a U.K. trade group, and more
Pharmalot Ed Silverman STAT Plus: Sandoz disavows U.K. trade group over dispute about promoting a biosimilar for multiple sclerosis
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about FDA dithering on pharma patents, WHO pandemic talks, and more
Pharmalot Ed Silverman STAT Plus: FDA is criticized for taking a ‘ministerial’ role in sorting out some pharma patents
Pharmalot Andrew Joseph STAT Plus: Pharmalittle: We’re reading about Sanofi licensing Novavax’s Covid shot, Moderna’s RSV vaccine, and more
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about Takeda restructuring, Pfizer settling Zantac suits, and more
Pharmalot Ed Silverman STAT Plus: A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about a boy dying in Pfizer trial; AstraZeneca yanking Covid shot, and more
Pharmalot Ed Silverman STAT Plus: Endo Health ordered to pay more than $1.5 billion in opioid criminal case
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about MDMA for PTSD, a CRISPR treatment for blindness, and more
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about FTC reviewing Novo-Catalent deal, Amneal opioid settlement, and more
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more
Pharmalot Ed Silverman STAT Plus: Gilead gets a boost from California court in a case over slow-walking an HIV drug
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about Wegovy and Ozempic sales, rising pharma layoffs, and more
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about FTC fighting ‘junk’ patents, Pfizer direct-to-consumer plans, and more
Pharmalot Ed Silverman STAT Plus: ‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period
Pharmalot Ed Silverman STAT Plus: FTC issues warnings on ‘junk’ patent listings for Ozempic and other drugs